238 related articles for article (PubMed ID: 27489947)
1. The Estrogen Receptor α-Cistrome Beyond Breast Cancer.
Droog M; Mensink M; Zwart W
Mol Endocrinol; 2016 Oct; 30(10):1046-1058. PubMed ID: 27489947
[TBL] [Abstract][Full Text] [Related]
2. A CRISPR-Cas9 screen identifies essential CTCF anchor sites for estrogen receptor-driven breast cancer cell proliferation.
Korkmaz G; Manber Z; Lopes R; Prekovic S; Schuurman K; Kim Y; Teunissen H; Flach K; Wit E; Galli GG; Zwart W; Elkon R; Agami R
Nucleic Acids Res; 2019 Oct; 47(18):9557-9572. PubMed ID: 31372638
[TBL] [Abstract][Full Text] [Related]
3. Unique ERalpha cistromes control cell type-specific gene regulation.
Krum SA; Miranda-Carboni GA; Lupien M; Eeckhoute J; Carroll JS; Brown M
Mol Endocrinol; 2008 Nov; 22(11):2393-406. PubMed ID: 18818283
[TBL] [Abstract][Full Text] [Related]
4. Impact of estrogen receptor beta on gene networks regulated by estrogen receptor alpha in breast cancer cells.
Chang EC; Frasor J; Komm B; Katzenellenbogen BS
Endocrinology; 2006 Oct; 147(10):4831-42. PubMed ID: 16809442
[TBL] [Abstract][Full Text] [Related]
5. Genome-wide identification of direct target genes implicates estrogen-related receptor alpha as a determinant of breast cancer heterogeneity.
Deblois G; Hall JA; Perry MC; Laganière J; Ghahremani M; Park M; Hallett M; Giguère V
Cancer Res; 2009 Aug; 69(15):6149-57. PubMed ID: 19622763
[TBL] [Abstract][Full Text] [Related]
6. Estrogen Receptor on the move: Cistromic plasticity and its implications in breast cancer.
Mayayo-Peralta I; Prekovic S; Zwart W
Mol Aspects Med; 2021 Apr; 78():100939. PubMed ID: 33358533
[TBL] [Abstract][Full Text] [Related]
7. Novel estrogen receptor-alpha binding sites and estradiol target genes identified by chromatin immunoprecipitation cloning in breast cancer.
Lin Z; Reierstad S; Huang CC; Bulun SE
Cancer Res; 2007 May; 67(10):5017-24. PubMed ID: 17510434
[TBL] [Abstract][Full Text] [Related]
8. [Study of the CpG methylation status of ER alpha gene in estrogen receptor alpha-negative breast cancer cell lines and the role of hydralazine demethylation].
Tang B; Jiang J
Zhonghua Bing Li Xue Za Zhi; 2005 May; 34(5):283-7. PubMed ID: 16181550
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-497 downregulation contributes to cell proliferation, migration, and invasion of estrogen receptor alpha negative breast cancer by targeting estrogen-related receptor alpha.
Han L; Liu B; Jiang L; Liu J; Han S
Tumour Biol; 2016 Oct; 37(10):13205-13214. PubMed ID: 27456360
[TBL] [Abstract][Full Text] [Related]
10. The role of 14-3-3β in transcriptional activation of estrogen receptor α and its involvement in proliferation of breast cancer cells.
Kim Y; Kim H; Jang SW; Ko J
Biochem Biophys Res Commun; 2011 Oct; 414(1):199-204. PubMed ID: 21946067
[TBL] [Abstract][Full Text] [Related]
11. Estrogen receptor alpha inhibits p53-mediated transcriptional repression: implications for the regulation of apoptosis.
Sayeed A; Konduri SD; Liu W; Bansal S; Li F; Das GM
Cancer Res; 2007 Aug; 67(16):7746-55. PubMed ID: 17699779
[TBL] [Abstract][Full Text] [Related]
12. Estrogen receptor beta2 negatively regulates the transactivation of estrogen receptor alpha in human breast cancer cells.
Zhao C; Matthews J; Tujague M; Wan J; Ström A; Toresson G; Lam EW; Cheng G; Gustafsson JA; Dahlman-Wright K
Cancer Res; 2007 Apr; 67(8):3955-62. PubMed ID: 17440111
[TBL] [Abstract][Full Text] [Related]
13. Genome-wide activity of unliganded estrogen receptor-α in breast cancer cells.
Caizzi L; Ferrero G; Cutrupi S; Cordero F; Ballaré C; Miano V; Reineri S; Ricci L; Friard O; Testori A; Corà D; Caselle M; Di Croce L; De Bortoli M
Proc Natl Acad Sci U S A; 2014 Apr; 111(13):4892-7. PubMed ID: 24639548
[TBL] [Abstract][Full Text] [Related]
14. Expression of estrogen receptor alpha, retinoic acid receptor alpha and cellular retinoic acid binding protein II genes is coordinately regulated in human breast cancer cells.
Lu M; Mira-y-Lopez R; Nakajo S; Nakaya K; Jing Y
Oncogene; 2005 Jun; 24(27):4362-9. PubMed ID: 15870697
[TBL] [Abstract][Full Text] [Related]
15. Genomic actions of estrogen receptor alpha: what are the targets and how are they regulated?
Welboren WJ; Sweep FC; Span PN; Stunnenberg HG
Endocr Relat Cancer; 2009 Dec; 16(4):1073-89. PubMed ID: 19628648
[TBL] [Abstract][Full Text] [Related]
16. The first decade of estrogen receptor cistromics in breast cancer.
Flach KD; Zwart W
J Endocrinol; 2016 May; 229(2):R43-56. PubMed ID: 26906743
[TBL] [Abstract][Full Text] [Related]
17. Gene expression signature of estrogen receptor alpha status in breast cancer.
Abba MC; Hu Y; Sun H; Drake JA; Gaddis S; Baggerly K; Sahin A; Aldaz CM
BMC Genomics; 2005 Mar; 6():37. PubMed ID: 15762987
[TBL] [Abstract][Full Text] [Related]
18. Estrogen receptor alpha/beta isoforms, but not betacx, modulate unique patterns of gene expression and cell proliferation in Hs578T cells.
Secreto FJ; Monroe DG; Dutta S; Ingle JN; Spelsberg TC
J Cell Biochem; 2007 Aug; 101(5):1125-47. PubMed ID: 17520659
[TBL] [Abstract][Full Text] [Related]
19. Endocrine therapy resistance can be associated with high estrogen receptor alpha (ERalpha) expression and reduced ERalpha phosphorylation in breast cancer models.
Kuske B; Naughton C; Moore K; Macleod KG; Miller WR; Clarke R; Langdon SP; Cameron DA
Endocr Relat Cancer; 2006 Dec; 13(4):1121-33. PubMed ID: 17158758
[TBL] [Abstract][Full Text] [Related]
20. Modulation of estrogen receptor alpha protein level and survival function by DBC-1.
Trauernicht AM; Kim SJ; Kim NH; Boyer TG
Mol Endocrinol; 2007 Jul; 21(7):1526-36. PubMed ID: 17473282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
